Sacituzumab tirumotecan
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Sacituzumab tirumotecan for carcinoma, transitional cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sacituzumab tirumotecan for endometrial neoplasms | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sacituzumab tirumotecan for neoplasm metastasis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sacituzumab tirumotecan for squamous cell carcinoma of head and neck | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sacituzumab tirumotecan for uterine cervical neoplasms | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |